Literature DB >> 24117896

Antilisterial activity of lactose monolaurate in milk, drinkable yogurt and cottage cheese.

Y Chen1, B Nummer, M K Walsh.   

Abstract

UNLABELLED: Lactose monolaurate (LML) was previously found to be an antimicrobial against Listeria monocytogenes in culture medium at concentrations between 3 and 5 mg ml(-1) . In this study, the microbial inhibitory activity of LML in dairy products inoculated with a 5-strain cocktail of clinical isolates of L. monocytogenes was investigated. Addition of LML at a concentration of 5 mg ml(-1) resulted in 4.4, 4.0 and 4.2 log reductions in 0.5% fat, 1% fat and 3.25% fat milks, respectively; 4.1, 4.4, and 3.5 log reductions in nonfat, 1% fat, and 1.5% fat yogurts, respectively; and 4.0 log reductions in both nonfat and 2% fat cottage cheese. The inhibitory effect of LML was only observed at 37°C and not 5°C. Experiments suggest that both the lauric acid and the esterified lactose moiety of LML play roles in the growth inhibition. SIGNIFICANCE AND IMPACT OF THE STUDY: A novel sugar ester, lactose monolaurate, inhibited the growth of a five-strain cocktail of Listeria monocytogenes in milk, yogurt and cottage cheese. This is the first report of the use of a sugar ester to inhibit the growth of Listeria in food systems.
© 2013 The Society for Applied Microbiology.

Entities:  

Keywords:  Listeria monocytogenes; cottage cheese; growth inhibition; lactose monolaurate; milk; sugar esters; yogurt

Mesh:

Substances:

Year:  2013        PMID: 24117896     DOI: 10.1111/lam.12169

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  2 in total

1.  Growth inhibitory properties of lactose fatty acid esters.

Authors:  Seung-Min Lee; Guneev Sandhu; Marie K Walsh
Journal:  Saudi J Biol Sci       Date:  2015-10-23       Impact factor: 4.219

2.  6'-O-Lactose Ester Surfactants as an Innovative Opportunity in the Pharmaceutical Field: From Synthetic Methods to Biological Applications.

Authors:  Michele Verboni; Simone Lucarini; Andrea Duranti
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.